Recreational and Medical Cannabis: What Providers Need to Know
SAPC and University of California Los Angeles (UCLA) Integrated Substance Abuse Programs (ISAP) hold a quarterly lecture series on current and emergent topics of interest in the substance use disorder research and treatment.
Leading researchers and treatment practitioners provide attendees with state-of-the-art, evidence-based information on substance abuse treatment and prevention.
UCLA-ISAP and SAPC currently provides continuing education units for counselors, clinicians, nurses, and other professionals in the substance abuse field who attend the lecture as well as CMEs for medical professionals.
Date & Time: Friday, September 30, 2022, 10:00 a.m. – 1:15 pm. PDT
Number of CE credits: 3.0
*The training course meets the qualifications for the provision of three (3.0) continuing education credits/ contact
hours (CEs/CEHs). UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or
LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for three (3.0) hours of continuing
education credit for LMFTs, LCSWs, LPCCS, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for
RADTs I/II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-00-445-1123), CATCs (ACCBC/CAADE, #CP40 872 C 0825), and CAODCs (CADTP, #151). CE credit will be awarded
six-eight weeks after the virtual training. Partial credit will not be available for those participants who arrive late or leave early.
Description:
This lecture series will describe the epidemiology of cannabis use in the United States. A brief overview of data on cannabis use in Los Angeles County will be
presented. Cannabis pharmacology will be discussed, as well as its acute and chronic physical and psychological effects. Current research on how cannabis is used as a
medical intervention and the legal questions that still surround medical cannabis, despite its legalization in many states, will be explored. Specific strategies that
clinicians can utilize to communicate effectively with patients who are using cannabis for either medical or recreational purposes or who are considering its use will be
presented. A panel discussion will follow this presentation featuring representatives from SAPC’s specialty provider network with particular experience or focus on Cannabis
use and Cannabis Use Disorder in youth, adult and transitional age youth (TAY) patients as well as representative from SAPC’s Harm Reduction unit.
UCLA Integrated Substance Abuse Programs (ISAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. UCLA ISAP maintains
responsibility for this program and its content.
UCLA Integrated Substance Abuse Programs (ISAP) CME is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.
UCLA ISAP CME designates that this training course qualifies for the provision of a maximum of one (3.0) AMA PRA Category 1 Credit™ of Continuing Medical Education (CME). Physicians
should claim only the credit commensurate with the extent of their participation in the activity.
The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course
is certified for AMA PRA Category 1 CreditTM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.